Cited by 1,871Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 176 of the 177 references it cites were found in a registry or an index, and 1 are not checked yet.

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

Open access

Talbot, Konrad, Wang, Hoau-Yan, Kazi, Hala, Han, Li-Ying, Bakshi, Kalindi P., Stucky, Andres, Fuino, Robert L., Kawaguchi, Krista R., Samoyedny, Andrew J., Wilson, Robert S., Arvanitakis, Zoe, Schneider, Julie A., Wolf, Bryan A., Bennett, David A., Trojanowski, John Q., Arnold, Steven E.·2012·Journal of Clinical Investigation

DOI 10.1172/jci59903PMC PMC3314463

Open this paper in CoChat — free account

Abstract

While a potential causal factor in Alzheimer's disease (AD), brain insulin resistance has not been demonstrated directly in that disorder. We provide such a demonstration here by showing that the hippocampal formation (HF) and, to a lesser degree, the cerebellar cortex in AD cases without diabetes exhibit markedly reduced responses to insulin signaling in the IR→IRS-1→PI3K signaling pathway with greatly reduced responses to IGF-1 in the IGF-1R→IRS-2→PI3K signaling pathway. Reduced insulin responses were maximal at the level of IRS-1 and were consistently associated with basal elevations in IRS-1 phosphorylated at serine 616 (IRS-1 pS⁶¹⁶) and IRS-1 pS⁶³⁶/⁶³⁹. In the HF, these candidate biomarkers of brain insulin resistance increased commonly and progressively from normal cases to mild cognitively impaired cases to AD cases regardless of diabetes or APOE ε4 status. Levels of IRS-1 pS⁶¹⁶ and IRS-1 pS⁶³⁶/⁶³⁹ and their activated kinases correlated positively with those of oligomeric Aβ plaques and were negatively associated with episodic and working memory, even after adjusting for Aβ plaques, neurofibrillary tangles, and APOE ε4. Brain insulin resistance thus appears to be an early and common feature of AD, a phenomenon accompanied by IGF-1 resistance and closely associated with IRS-1 dysfunction potentially triggered by Aβ oligomers and yet promoting cognitive decline independent of classic AD pathology.

Integrity signals

Registry

Crossref · 10.1172/jci59903

Cites

176 of 177 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

RETRACTED: Effects of high-fat diet on insulin receptor function in rat hippocampus and the level of neuronal corticosterone
Pratchayasakul, W., Kerdphoo, S., Petsophonsakul, P., Pongchaidecha, A., Chattipakorn, N., & Chattipakorn, S. C. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.02.003 · Cited by 206
Retracted
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 4×
“The other was the hippocampal formation (HF; consisting of hippocampus fields CA1–CA3, the dentate gyrus, and the subiculum), which develops marked pathology starting early in the disorder (61, 63).”
BackgroundInfluential
Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Self-citation
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
Shankar, G. M., Li, S., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1782 · Cited by 3,685
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
A comprehensive definition for metabolic syndrome
Huang, P. L. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001180 · Cited by 2,223
Risk of dementia in diabetes mellitus: a systematic review
Biessels, G. J., Staekenborg, S., Brunner, E., Brayne, C., & Scheltens, P. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70284-2 · Cited by 2,187
Studies on the structure of the cerebral cortex. II. Continuation of the study of the ammonic system.
de Nó, R. L. (1934) · Cited by 1,974

Flagged first, then by citations

Show all 176 references

Research works printed but not linked: 5

Cheatham, 1995, Endocr Rev., 16, 117
Combettes-Souverain, 1998, Diabetes Metab., 24, 477
10.1210/en.143.1.276 · DOI
García-Lara, 2010, Rev Invest Clin., 62, 343
Lorente de Nò, 1934, J Psychol Neurol., 46, 113

Sorted by citations

Items 701–800 of 1,005

Potentials of incretin‐based therapies in dementia and stroke in type 2 diabetes mellitus
Groeneveld, O. N., Kappelle, L. J., & Biessels, G. J. (2015) · Journal of Diabetes Investigation · doi:10.1111/jdi.12420 · Cited by 42
Cognitive Functions in Middle Aged Individuals Are Related to Metabolic Disturbances and Aerobic Capacity: A Cross-Sectional Study
Pedersen, M., Pedersen, K. K., Brüünsgaard, H., Krabbe, K. S., Thomsen, C., Færch, K., Pedersen, B. K., & Mortensen, E. L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051132 · Cited by 42
High-fat diet impairs spatial memory and hippocampal intrinsic excitability and sex-dependently alters circulating insulin and hippocampal insulin sensitivity
Underwood, E. L., & Thompson, L. T. (2016) · Biology of Sex Differences · doi:10.1186/s13293-016-0060-3 · Cited by 42
Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α‐synuclein, amyloid‐β and insulin resistance in neurodegenerative diseases
Clark, I. A., & Vissel, B. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14471 · Cited by 42
Age‐associated cholesterol reduction triggers brain insulin resistance by facilitating ligand‐independent receptor activation and pathway desensitization
Martín‐Segura, A., Ahmed, T., Casadomé‐Perales, Á., Palomares-Pérez, I., Palomer, E., Kerstens, A., Munck, S., Balschun, D., & Dotti, C. G. (2019) · Aging Cell · doi:10.1111/acel.12932 · Cited by 42
Adenovirus-Mediated Transduction of Insulin-Like Growth Factor 1 Protects Hippocampal Neurons from the Toxicity of Aβ Oligomers and Prevents Memory Loss in an Alzheimer Mouse Model
Sellés, M. C., Fortuna, J. T. S., Zappa-Villar, M. F., de Faria, Y. P. R., de Souza, A. S., Suemoto, C. K., Leite, R. E. P., Rodriguez, R. D., Grinberg, L. T., Reggiani, P. C., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01827-y · Cited by 42
Does hyperglycemia downregulate glucose transporters in the brain?
Leão, L. L., Tangen, G. G., Barca, M. L., Engedal, K., Santos, S. H. S., Machado, F. S. M., de Paula, A. M. B., & Monteiro-Júnior, R. S. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109614 · Cited by 42
Metabolic Defects Caused by High-Fat Diet Modify Disease Risk through Inflammatory and Amyloidogenic Pathways in a Mouse Model of Alzheimer’s Disease
Reilly, A. M., Tsai, A. P., Lin, P. B., Ericsson, A. C., Oblak, A. L., & Ren, H. (2020) · Nutrients · doi:10.3390/nu12102977 · Cited by 42
Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon‐like peptide‐1 receptor agonists
Yassine, H. N., Solomon, V. A., Thakral, A., Sheikh‐Bahaei, N., Chui, H. C., Braskie, M. N., Schneider, L. S. S., & Talbot, K. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12474 · Cited by 42
Self-citation
Sixty years old is the breakpoint of human frontal cortex aging
Cabré, R., Naudí, A., Domínguez-González, M., Ayala, V., Jové, M., Mota‐Martorell, N., Piñol‐Ripoll, G., Gil‐Villar, M. P., Rué, M., Portero‐Otín, M., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.010 · Cited by 42
The neurobiology of insulin-like growth factor I: From neuroprotection to modulation of brain states
Núñez, Á., Zegarra-Valdivia, J. A., de Sevilla, D. F., Pignatelli, J., & Aleman, I. T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02136-6 · Cited by 41
Impaired firing properties of dentate granule neurons in an Alzheimer's disease animal model are rescued by PPARγ agonism
Nenov, M. N., Tempia, F., Denner, L. A., Dineley, K. T., & Laezza, F. (2014) · Journal of Neurophysiology · doi:10.1152/jn.00419.2014 · Cited by 41
Cognitively impaired elderly exhibit insulin resistance and no memory improvement with infused insulin
Morris, J. K., Vidoni, E. D., Mahnken, J. D., Montgomery, R. N., Johnson, D. K., Thyfault, J. P., & Burns, J. M. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.11.005 · Cited by 41
Rapidly progressive cognitive decline associated with teprotumumab in thyroid eye disease
Hoang, T. D., Nguyen, N. T., Chou, E. L., & Shakir, M. K. M. (2021) · BMJ Case Reports · doi:10.1136/bcr-2021-242153 · Cited by 41
Metabolic determinants of Alzheimer’s disease: A focus on thermoregulation
Tournissac, M., Leclerc, M., Valentin‐Escalera, J., Vandal, M., Bosoi, C. R., Planel, E., & Calon, F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101462 · Cited by 41
New treatment approaches for Alzheimer’s disease: preclinical studies and clinical trials centered on antidiabetic drugs
Katsenos, A. P., Davri, A. S., Simos, Y. V., Nikas, I. P., Bekiari, C., Paschou, S. Α., Peschos, D., Konitsiotis, S., Vezyraki, P., & Tsamis, K. I. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2022.2022122 · Cited by 41
Targeting Systemic Innate Immune Cells as a Therapeutic Avenue for Alzheimer Disease
Pons, V., & Rivest, S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000400 · Cited by 41
The Role of Insulin Signaling in Hippocampal-Related Diseases: A Focus on Alzheimer’s Disease
Liu, Q., Wang, Z., Cao, J., Dong, Y., & Chen, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232214417 · Cited by 42
Insulin-Mediated Changes in Tau Hyperphosphorylation and Autophagy in a Drosophila Model of Tauopathy and Neuroblastoma Cells
Chatterjee, S., Ambegaokar, S. S., Jackson, G. R., & Mudher, A. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00801 · Cited by 40
Insulin Protects Cortical Neurons Against Glutamate Excitotoxicity
Krasilnikova, I. A., Surin, A. M., Sorokina, E. G., Fisenko, А. P., Boyarkin, D., Balyasin, M. V., Demchenko, A. G., Анатольевич, П. И., & Pinelis, V. G. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01027 · Cited by 40
Neurodegeneration: Diagnosis, Prevention, and Therapy
Poddar, M. K., Chakraborty, A., & Banerjee, S. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94950 · Cited by 40
Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
Poor, S. R., Ettcheto, M., Cano, A. C., Sánchez‐López, E., Manzine, P. R., Olloquequi, J., Camins, A., & Javan, M. (2021) · Pharmaceuticals · doi:10.3390/ph14090890 · Cited by 41
ZiBuPiYin Recipe Protects db/db Mice from Diabetes-Associated Cognitive Decline through Improving Multiple Pathological Changes
Chen, J., Liang, L., Zhan, L., Zhou, Y., Zheng, L., Sun, X., Gong, J., Sui, H. X., Jiang, R., Zhang, F.-L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091680 · Cited by 40
Mild Cognitive Impairment: An Update in Parkinson’s Disease and Lessons Learned from Alzheimer’s Disease
Goldman, J. G., Aggarwal, N. T., & Schroeder, C. (2015) · Neurodegenerative Disease Management · doi:10.2217/nmt.15.34 · Cited by 40
Brain-Defective Insulin Signaling Is Associated to Late Cognitive Impairment in Post-Septic Mice
Neves, F., Marques, P. T., Barros‐Aragão, F. G. Q., Nunes, J. B., Venancio, A. M., Cozachenco, D., Frozza, R. L., Passos, G. F., da Costa, R., de Oliveira, J., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0307-3 · Cited by 40
ApoE4 expression accelerates hippocampus-dependent cognitive deficits by enhancing Aβ impairment of insulin signaling in an Alzheimer’s disease mouse model
Chan, E. S., Shetty, M. S., Sajikumar, S., Chen, C., Soong, T. W., & Wong, B.-S. (2016) · Scientific Reports · doi:10.1038/srep26119 · Cited by 39
Docosahexaenoic acid enhances hippocampal insulin sensitivity to promote cognitive function of aged rats on a high-fat diet
Xu, J., Ni, B., Ma, C., Rong, S., Gao, H. Y., Zhang, L., Xia, X., Huang, Q., Deng, Q., & Huang, F. (2022) · Journal of Advanced Research · doi:10.1016/j.jare.2022.04.015 · Cited by 39
Intestinal endogenous metabolites affect neuroinflammation in 5×FAD mice by mediating “gut-brain” axis and the intervention with Chinese Medicine
Gu, X., Zhou, Y., Zhang, Y., Wang, L., Gao, W., Luo, K., Sun, B., Li, T., Wang, H., Si, N., et al. (2024) · Alzheimer s Research & Therapy · doi:10.1186/s13195-024-01587-5 · Cited by 39
Self-citation
Loss of insulin signaling in microglia impairs cellular uptake of Aβ and neuroinflammatory response exacerbating AD-like neuropathology
Chen, W., Liu, X., Muñoz, V. R., & Kahn, C. R. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2501527122 · Cited by 42
A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer’s Disease and Type 2 Diabetes Mellitus
Kaminari, A., Tsilibary, E. C., & Tzinia, A. K. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180035 · Cited by 39
Brain insulin resistance impairs hippocampal plasticity
Spinelli, M., Fusco, S., & Grassi, C. (2020) · Vitamins and hormones · doi:10.1016/bs.vh.2020.04.005 · Cited by 39
Mini‐review: Role of the PI3K/Akt pathway and tyrosine phosphatases in Alzheimer's disease susceptibility
Curtis, D., & Bandyopadhyay, S. (2020) · Annals of Human Genetics · doi:10.1111/ahg.12410 · Cited by 39
Non-cognitive symptoms and related conditions in the Alzheimer’s disease: a literature review
Raudino, F. (2013) · Neurological Sciences · doi:10.1007/s10072-013-1424-7 · Cited by 39
Integrating Metabolism and Longevity Through Insulin and IGF1 Signaling
Sadagurski, M., & White, M. F. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.11.008 · Cited by 39
Effects of Bisphenol A on glucose homeostasis and brain insulin signaling pathways in male mice
Fang, F., Chen, D., Yu, P., Qian, W., Zhou, J., Liu, J., Gao, R., Wang, J., & Xiao, H. (2015) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2015.01.017 · Cited by 38
Hippocampal Growth Factor and Myokine Cathepsin B Expression following Aerobic and Resistance Training in 3xTg-AD Mice
Pena, G. S., Paez, H. G., Johnson, T. K., Halle, J. L., Carzoli, J. P., Visavadiya, N. P., Zourdos, M. C., WHITEHURST, M. A., & Khamoui, A. V. (2020) · International Journal of Chronic Diseases · doi:10.1155/2020/5919501 · Cited by 38
Small molecule targeting of SHIP1 and SHIP2
Kerr, W. G., Pedicone, C., Dormann, S., Pacherille, A., & Chisholm, J. D. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190775 · Cited by 38
Oxidative Stress in the Pathogenesis of Alzheimer's Disease and Cerebrovascular Disease with Therapeutic Implications
Jurcău, A., & Simion, A. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200303121016 · Cited by 38
The Role of Bilirubin and the Other “Yellow Players” in Neurodegenerative Diseases
Jayanti, S. D., Vı́tek, L., Tiribelli, C., & Gazzin, S. (2020) · Antioxidants · doi:10.3390/antiox9090900 · Cited by 38
Intranasal insulin and orexins to treat age-related cognitive decline
Erichsen, J. M., Calva, C. B., Reagan, L. P., & Fadel, J. R. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113370 · Cited by 38
Insulin Resistance as a Common Link Between Current Alzheimer’s Disease Hypotheses
Alves, S. S., da Silva-Júnior, R. M. P., Servilha‐Menezes, G., Homolak, J., Šalković‐Petrišić, M., & Garcia‐Cairasco, N. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210234 · Cited by 39
Blood Neuroexosomal Mitochondrial Proteins Predict Alzheimer Disease in Diabetes
Chi, H., Yao, R., Sun, C., Leng, B., Shen, T., Wang, T., Zhang, S., Li, M., Yang, Y., Sun, H., et al. (2022) · Diabetes · doi:10.2337/db21-0969 · Cited by 38
Antidiabetic therapies and Alzheimer disease
Bendlin, B. B. (2019) · Phlebolymphology · doi:10.31887/dcns.2019.21.1/bbendlin · Cited by 39
Reducing PDK1/Akt Activity: An Effective Therapeutic Target in the Treatment of Alzheimer’s Disease
Yang, S., Du, Y., Zhao, X., Wu, C., & Yu, P. (2022) · Cells · doi:10.3390/cells11111735 · Cited by 38
Role of insulin resistance in Alzheimer’s disease
Cai, Z., Xiao, M., Chang, L., & Yan, L. (2014) · Metabolic Brain Disease · doi:10.1007/s11011-014-9631-3 · Cited by 38
Exploring Curcumin-Loaded Lipid-Based Nanomedicine as Efficient Targeted Therapy for Alzheimer’s Diseases
Far, B. F., Safaei, M., Pourmolaei, A., AdibAmini, S., Shirdel, S., Shirdel, S., Emadi, R., & Kaushik, A. K. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c00112 · Cited by 37
Neural Metabolic Networks: Key Elements of Healthy Brain Function
Madrer, N., Perera, N. D., Uccelli, N. A., Abbondanza, A., Andersen, J. V., Carsana, E. V., Demmings, M. D., Fernandez, R. F., de Fragas, M. G., Gbadamosi, I., et al. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70084 · Cited by 37
Can insulin signaling pathways be targeted to transport Aβ out of the brain?
Vandal, M., Bourassa, P., & Calon, F. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00114 · Cited by 37
Linking Alzheimer’s Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation
Kamal, M. A., Priyamvada, S., Anbazhagan, A. N., Jabir, N. R., Tabrez, S. S. M., & Greig, N. H. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660137 · Cited by 37
New Therapeutic Strategies for Lewy Body Dementias
Velayudhan, L., Ffytche, D. H., Ballard, C. G., & Aarsland, D. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0778-2 · Cited by 37
Iron metabolism in diabetes-induced Alzheimer’s disease: a focus on insulin resistance in the brain
Chung, J. Y., Kim, H.-S., & Song, J. (2018) · BioMetals · doi:10.1007/s10534-018-0134-2 · Cited by 37
Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer’s Disease
Robinson, A., Lubitz, I., Atrakchi, D., Licht-Murava, A., Katsel, P., LeRoith, D., Zaltsman, S. L., Haroutunian, V. H., & Beeri, M. S. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-1257-9 · Cited by 37
Outcomes and clinical implications of intranasal insulin administration to the central nervous system
Santiago, J. C. P., & Hallschmid, M. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.03.007 · Cited by 37
Understanding the link between insulin resistance and Alzheimer’s disease: Insights from animal models
Silva, N. M. L. E., Gonçalves, R. A., Boehnke, S. E., Forny‐Germano, L., Munoz, D. P., & Felice, F. G. D. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.03.016 · Cited by 37
Melatonin attenuates streptozotocin-induced Alzheimer-like features in hyperglycemic rats
Kamsrijai, U., Wongchitrat, P., Nopparat, C., Satayavivad, J., & Govitrapong, P. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.104601 · Cited by 37
Insulin activates microglia and increases COX-2/IL-1β expression in young but not in aged hippocampus
Haas, C. B., de Carvalho, A. K., Muller, A. P., Eggen, B. J. L., & Portela, L. V. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146884 · Cited by 37
Acute exercise increases circulating IGF-1 in Alzheimer’s disease patients, but not in older adults without dementia
Stein, A. M., da Silva, T. M. V., Coelho, F. G. D. M., Rueda, A. V. L., Camarini, R., & Galduróz, R. F. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112903 · Cited by 37
Enhancement of Insulin/PI3K/Akt Signaling Pathway and Modulation of Gut Microbiome by Probiotics Fermentation Technology, a Kefir Grain Product, in Sporadic Alzheimer’s Disease Model in Mice
Sayed, N. S. E., Kandil, E. A., & Ghoneum, M. H. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.666502 · Cited by 38
Potential Role of Akkermansia muciniphila in Parkinson’s Disease and Other Neurological/Autoimmune Diseases
Fang, X., Li, F., & Hong, D. (2021) · Current Medical Science · doi:10.1007/s11596-021-2464-5 · Cited by 37
Finding memo: versatile interactions of the VPS10p-Domain receptors in Alzheimer’s disease
Salasova, A., Monti, G., Andersen, O. M., & Nykjaer, A. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00576-2 · Cited by 42
High-Fat Diets in Animal Models of Alzheimer’s Disease: How Can Eating Too Much Fat Increase Alzheimer’s Disease Risk?
Valentin‐Escalera, J., Leclerc, M., & Calon, F. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230118 · Cited by 37
Insulin Attenuates Beta-Amyloid-Associated Insulin/Akt/EAAT Signaling Perturbations in Human Astrocytes
Han, X., Yang, L., Du, H., Sun, Q., Wang, X., Cong, L., Liu, X., Yin, L., Li, S., & Du, Y. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0268-5 · Cited by 36
Low Serum Insulin-Like Growth Factor-I Predicts Cognitive Decline in Alzheimer’s Disease
Vidal, J., Hanon, O., Funalot, B., Brunel, N., Viollet, C., Rigaud, A., Seux, M., Bouc, Y. L., Epelbaum, J., & Duron, E. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-151162 · Cited by 36
The impact of hippocampal lesions on trace-eyeblink conditioning and forebrain–cerebellar interactions.
Weiss, C., & Disterhoft, J. F. (2015) · Behavioral Neuroscience · doi:10.1037/bne0000061 · Cited by 36
Chronic synaptic insulin resistance after traumatic brain injury abolishes insulin protection from amyloid beta and tau oligomer-induced synaptic dysfunction
Franklin, W. F., Krishnan, B., & Taglialatela, G. (2019) · Scientific Reports · doi:10.1038/s41598-019-44635-z · Cited by 36
A GLP-1/GIP/Gcg receptor triagonist improves memory behavior, as well as synaptic transmission, neuronal excitability and Ca2+ homeostasis in 3xTg-AD mice
Li, T., Jiao, J., Su, Q., Hölscher, C., Zhang, J., Yan, X., Zhao, H., Cai, H.-Y., & Qi, J. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108042 · Cited by 36
A Comprehensive Review of Alzheimer’s Association with Related Proteins: Pathological Role and Therapeutic Significance
Kumar, D., Sharma, A., & Sharma, L. K. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200203101828 · Cited by 36
Intermittent fasting promotes adult hippocampal neuronal differentiation by activating GSK‐3β in 3xTg‐AD mice
Li, W., Wu, M., Zhang, Y., Wei, X., Zang, J., Liu, Y., Wang, Y., Gong, C., & Wei, W. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15105 · Cited by 37
Intranasal insulin ameliorates cognitive impairment in a rat model of Parkinson's disease through Akt/GSK3β signaling pathway
Yang, L., Zhang, X., Li, S., Wang, H., Zhang, X., Liu, L., & Xie, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118159 · Cited by 36
Self-citation
Exploiting Common Aspects of Obesity and Alzheimer’s Disease
Tabassum, S., Misrani, A., & Yang, L. (2020) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2020.602360 · Cited by 36
A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer’s Disease, the 5XFAD Mouse
López-Gambero, A. J., Rosell‐Valle, C., Vera, D. M., Navarro, J. A., Vargas, A., Rivera, P., Sanjuan, C., de Fonseca, F. R., & Suárez, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105365 · Cited by 37
Transcriptomic and Genetic Associations between Alzheimer’s Disease, Parkinson’s Disease, and Cancer
Forés-Martos, J., Boullosa, C., Domínguez, D. R., Sánchez-Valle, J., Suay‐García, B., Climent, J., Falcó, A., Valencia, A., Puig‐Butillé, J. A., Puig, S., et al. (2021) · Cancers · doi:10.3390/cancers13122990 · Cited by 36
Brain-Derived Exosomal Proteins as Effective Biomarkers for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Kim, K. Y., Shin, K. Y., & Chang, K. (2021) · Biomolecules · doi:10.3390/biom11070980 · Cited by 36
Differential involvement of insulin receptor substrate (IRS)-1 and IRS-2 in brain insulin signaling is associated with the effects on amyloid pathology in a mouse model of Alzheimer's disease
Ochiai, T., Sano, T., Nagayama, T., Kubota, N., Kadowaki, T., Wakabayashi, T., & Iwatsubo, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105510 · Cited by 36
Role of IGF-1 in neuroinflammation and cognition deficits induced by sleep deprivation
Wan, Y., Gao, W., Zhou, K., Liu, X., Jiang, W., Xue, R., & Wu, W. (2022) · Neuroscience Letters · doi:10.1016/j.neulet.2022.136575 · Cited by 36
Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials
Mantik, K. E. K., Kim, S., Gu, B., Moon, S., Kwak, H., Park, D., & Kang, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411450 · Cited by 36
Targeting Insulin for Alzheimer’s Disease: Mechanisms, Status and Potential Directions
Lee, J. H., Jahrling, J. B., Denner, L. A., & Dineley, K. T. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-179923 · Cited by 36
The Role of Insulin Resistance and Protein O-GlcNAcylation in Neurodegeneration
Ansari, S. A., & Emerald, B. S. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00473 · Cited by 36
Dysfunctional microglia and tau pathology in Alzheimer’s disease
Ayyubova, G. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0087 · Cited by 36
Association between anxiety and metabolic syndrome: An updated systematic review and meta-analysis
Ji, S., Chen, Y., Zhou, Y., Cao, Y., Li, X., Ding, G., & Tang, F. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1118836 · Cited by 35
Brain insulin resistance and Alzheimer’s disease: a systematic review
Andrade, L. J. D. O., de Oliveira, L. M., Bittencourt, A. M. V., Lourenço, L. G. D. C., & de Oliveira, G. C. M. (2024) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2023-0032 · Cited by 35
Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges
Tran, J., Parekh, S., Rockcole, J., Wilson, D., & Parmar, M. S. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.123001 · Cited by 35
The IGF System and Aging
Conover, C. A., & Oxvig, C. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae029 · Cited by 35
Insulin prevents mitochondrial generation of H2O2 in rat brain
Muller, A. P., Haas, C. B., Camacho-Pereira, J., Brochier, A., Gnoatto, J. A., Zimmer, E. R., Souza, D. O., Galina, A., & Portela, L. V. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.03.007 · Cited by 35
Intranasal Neuropeptide Administration To Target the Human Brain in Health and Disease
Spetter, M. S., & Hallschmid, M. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00047 · Cited by 35
Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result
Westwood, S., Baird, A. L., Hye, A., Ashton, N. J., Nevado‐Holgado, A. J., Anand, S. N., Liu, B., Newby, D., Bazenet, C. E., Kiddle, S. J., et al. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00409 · Cited by 35
Manganese Acts upon Insulin/IGF Receptors to Phosphorylate AKT and Increase Glucose Uptake in Huntington’s Disease Cells
Bryan, M. R., Nordham, K. D., Rose, D. I. R., O’Brien, M. T., Joshi, P. K., Foshage, A. M., Gonçalves, F. M., Nitin, R., Uhouse, M. A., Aschner, M., et al. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01824-1 · Cited by 35
Sleep Disturbances and Cognitive Impairment in the Course of Type 2 Diabetes-A Possible Link
Brzecka, A., Madetko‐Alster, N., Nikolenko, V. N., Ashraf, G. M., Ejma, M., Leszek, J., Daroszewski, C., Sarul, K., Михалева, Л. М., Somasundaram, S. G., et al. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200309101750 · Cited by 35
Alogliptin reversed hippocampal insulin resistance in an amyloid-beta fibrils induced animal model of Alzheimer's disease
Rahman, S. O., Kaundal, M., Salman, M., Shrivastava, A., Parvez, S., Panda, B. P., Akhter, M., Akhtar, M., & Najmi, A. K. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173522 · Cited by 35
Altered Insulin Receptor Substrate 1 Phosphorylation in Blood Neuron-Derived Extracellular Vesicles From Patients With Parkinson’s Disease
Chou, S., Chan, L., Chung, C., Chiu, J.-Y., Hsieh, Y., & Hong, C. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.564641 · Cited by 35
Key Disease Mechanisms Linked to Alzheimer’s Disease in the Entorhinal Cortex
Bottero, V., Powers, D., Yalamanchi, A., Quinn, J. P., & Potashkin, J. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083915 · Cited by 35
A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer’s Disease1
Cai, H.-Y., Yang, D., Qiao, J., Yang, J.-T., Wang, Z.-J., Wu, M.-N., Qi, J.-S., & Hölscher, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210256 · Cited by 35
Long-Term Effects of Intracerebroventricular Streptozotocin Treatment on Adult Neurogenesis in the Rat Hippocampus
Sun, P., Knezović, A., Parlak, M., Cuber, J., Karabeg, M. M., Deckert, J., Riederer, P. F., Hua, Q., Šalković‐Petrišić, M., & Schmitt, A. G. (2015) · Current Alzheimer Research · doi:10.2174/1567205012666150710112147 · Cited by 35
Iron homeostasis and insulin sensitivity: unraveling the complex interactions
Sobieska, K., Buczyńska, A., Kretowski, A. J., & Popławska‐Kita, A. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-024-09908-7 · Cited by 34
Pharmacological activation of PPAR gamma ameliorates vascular endothelial insulin resistance via a non-canonical PPAR gamma-dependent nuclear factor-kappa B trans-repression pathway
Zhang, Y., Zhan, R.-X., Chen, J.-Q., Gao, Y., Chen, L., Kong, Y., Zhong, X.-J., Liu, M., Chu, J.-J., Yan, G.-Q., et al. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.02.004 · Cited by 34
Late-onset dementia: a mosaic of prototypical pathologies modifiable by diet and lifestyle
Mattson, M. P. (2015) · npj Aging and Mechanisms of Disease · doi:10.1038/npjamd.2015.3 · Cited by 34
The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer’s disease
Trombetta, B. A., Carlyle, B. C., Koenig, A. M., Shaw, L. M. J., Trojanowski, J. Q., Wolk, D. A., Locascio, J. J., & Arnold, S. E. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193707 · Cited by 34
Self-citation
Alpha lipoic acid and metformin alleviates experimentally induced insulin resistance and cognitive deficit by modulation of TLR2 signalling
Ahuja, S., Uniyal, A., Akhtar, A., & Sah, S. P. (2019) · Pharmacological Reports · doi:10.1016/j.pharep.2019.02.016 · Cited by 34
Shared signaling pathways in Alzheimer’s and metabolic disease may point to new treatment approaches
Suresh, J., Khor, I. W., Kaur, P., Heng, H. L., Torta, F. T., Dawe, G. S., Tai, E. S., & Tolwinski, N. S. (2020) · FEBS Journal · doi:10.1111/febs.15540 · Cited by 34
Multifaceted Alzheimer’s Disease: Building a Roadmap for Advancement of Novel Therapies
Kaur, D., Behl, T., Sehgal, A., Singh, S., Sharma, N., & BUNGAU, S. G. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03415-w · Cited by 34

Authors: Talbot, K., Wang, H.-Y., Kazi, H., Han, L.-Y., Bakshi, K. P., Stucky, A., Fuino, R. L., Kawaguchi, K. R., Samoyedny, A. J., Wilson, R. S., Arvanitakis, Z., Schneider, J. A., Wolf, B. A., Bennett, D. A., Trojanowski, J. Q., & Arnold, S. E.
Affiliations: University of Pennsylvania (US)
City University of New York (US)
Rush University Medical Center (US)
Children's Hospital of Philadelphia (US)
Corresponding author: Talbot, Konrad
ORCID: Talbot, Konrad
Wang, Hoau-Yan
Arvanitakis, Zoe
Schneider, Julie A.
Bennett, David A.
Trojanowski, John Q.
Arnold, Steven E.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2012-04-02
Volume: 122
Issue: 4
Pages: 1316-1338
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci59903
PMC: PMC3314463
OpenAlex: W1982795519
Cited by: 1,871
References: 176
Citations by year: 2026: 118 · 2025: 147 · 2024: 120 · 2023: 114 · 2022: 157 · 2021: 168 · 2020: 175 · 2019: 145 · 2018: 146 · 2017: 109 · 2016: 116 · 2015: 125 · 2014: 111 · 2013: 93 · 2012: 26
FWCI: 75.52
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: Alzheimer's Association (P30AG10161, R01 AG15819)
University of Pennsylvania
Rush University (R01 AG15819)
T.L.L Temple Foundation
National Institute on Aging (P30AG010124, R01AG015819, AG-10124, P30AG010161)
National Institute of General Medical Sciences (R25GM056833)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, brain insulin resistance, IGF-1 resistance, IRS-1, IRS-1 serine phosphorylation, insulin signaling, PI3K signaling, IGF-1 receptor, hippocampus, cerebellum, amyloid-beta oligomers, cognitive decline, episodic memory, working memory, APOE ε4, neurofibrillary tangles, mild cognitive impairment
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Brain, Cerebellar Cortex, Cognition Disorders, Drug Resistance, Female, Glucose, Hippocampus, Humans, Insulin, Insulin Resistance, Insulin-Like Growth Factor I, Male, Middle Aged, Phosphorylation, Phosphoserine, Protein Processing, Post-Translational, Recombinant Proteins, Signal Transduction, Diabetes Complications, Apolipoprotein E4, Insulin Receptor Substrate Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks